Kanayo Ikeh

Dr. Kanayo Ikeh

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2021 in Cancers
Verified
Journal Article
Open access
PDF file
KIKanayo Ikeh
Kanayo Ikeh
ELErica Lamkin
Erica Lamkin
ACAndrew Crompton
Andrew Crompton
JDJamie Deutsch
Jamie Deutsch
Kira FisherKira Fisher
Kira Fisher
NCNimrat Chatterjee
Nimrat Chatterjee
Cancer therapy resistance is a persistent clinical challenge. Recently, inhibition of the mutagenic translesion synthesis (TLS) protein REV1 was shown to enhance tumor cell response to chemotherapy by triggering senescence hallmarks. These observations suggest REV1’s important role in determining cancer cell response to chemotherapy. Whether REV1 inhibition would similarly sensitize cancer cells to radiation treatment is unknown. This study reports a lack of radiosensitization in response to REV1 inhibition by small molecule inhibitors in ionizing radiation-exposed cancer cells. Instead, REV1 inhibition unexpectedly triggers autophagy, which is a known biomarker of radioresistance. We report a possible role of the REV1 TLS protein in determining cancer treatment outcomes depending upon the type of DNA damage inflicted. Furthermore, we discover that REV1 inhibition directly triggers autophagy, an uncharacterized REV1 phenotype, with a significant bearing on cancer treatment regimens.

16 September 2025 in bioRxiv
Verified
Preprint
Open access
ASAva Siegel
Ava Siegel
DADaniel Almstead
Daniel Almstead
NKNaveen Kothandaraman
Naveen Kothandaraman
JRJessica Reich
Jessica Reich
ELErica Lamkin
Erica Lamkin
NCNimrat Chatterjee
Nimrat Chatterjee
Trinucleotide repeat (TNR) instability has been implicated in the pathogenesis of numerous neurodegenerative disorders. Because TNR instability causes mutagenesis of the underlying gene, we refer to the repeat instability phenomenon as TNR mutagenesis in this study. While germline expansions destabilize TNR to cause disease anticipation, somatic cell TNR instability drives earlier onset of symptoms and further disease progression. However, the drivers behind these repeat length changes remain unclear. Current models suggest that DNA replication slippage events and the action of genome instability pathways, such as DNA repair, cause TNR mutagenesis. Whether mutagenic polymerases from the translesion synthesis (TLS) pathway result in TNR instability is unclear. TLS polymerases are best at bypassing difficult-to-replicate DNA regions due to bulky lesions or gaps in DNA. While some effects of TLS polymerases on TNR instability have been explored in lower organisms, evidence in human cells is lacking. Using a quantitative GFP reporter with expanded CAG repeats, we show that inhibition of the TLS polymerase REV1 by its inhibitor, JH-RE-06, or siRNA knockdown increases TNR instability and the underlying mutability. These results suggest that REV1 protects Trinucleotide repeat length mutagenesis through potential continuous DNA synthesis when replicative polymerases stall ahead of repeat secondary structures. Collectively, we present evidence of the role of the TLS pathway in TNR instability, with potential implications for understanding mutability mechanisms, disease biology, and therapeutic targeting.

31 December 2025 in Genes
Verified
Journal Article
Open access
PDF file
BBBrailey Buntin
Brailey Buntin
MGMadison Guyette
Madison Guyette
VGVihit Gupta
Vihit Gupta
KIKanayo Ikeh
Kanayo Ikeh
SBSombodhi Bhattacharya
Sombodhi Bhattacharya
NCNimrat Chatterjee
Nimrat Chatterjee
Background: Genomic integrity is crucial to the cellular life cycle, which involves a tightly regulated process where cells progress through specific phases to ensure that fully replicated, undamaged DNA is inherited by daughter cells. Any dysfunction in this process or unrepaired DNA damage leads to cell cycle arrest and programmed cell death. Cancer cells are known to exploit these mechanisms to continue dividing. Usually, DNA damage arrests replication, allowing the DNA Damage Response (DDR) pathway to activate, which repairs the DNA or bypasses the damage to support cell survival and preserve genome integrity. For DNA damage bypass or translesion synthesis (TLS), a group of low-fidelity polymerases perform error-prone DNA synthesis opposite damaged bases, where REV1 functions as the main scaffolding protein. Previously, we reported non-TLS functions of REV1, including its role in triggering DNA damage-dependent specific DNA metabolic processes. Methods and Results: In this study, we demonstrate that REV1 plays a significant role in cell cycle progression and that its loss causes arrest at the G2/M phase in flow cytometry analysis. This unexpected phenotype includes dysregulation of G2/M regulators, such as Cyclin B1 and tubulins, in REV1-deficient cells compared to controls, as quantified by Western blot. Additionally, phosphorylation of histone H3 at serine 28 was significantly reduced in these REV1-deficient cells. These G2/M arrest features were even more pronounced in REV1-deficient cells treated with the tubulin inhibitor colchicine. Conclusions: Overall, this study reveals a previously unrecognized link between REV1 TLS polymerase inhibition and the G2/M cell cycle arrest.

28 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
RHRebekah Honce
Rebekah Honce
IMInessa Manuelyan
Inessa Manuelyan
CSChloe Schiff
Chloe Schiff
EBEmily Van Beek
Emily Van Beek
KIKanayo Ikeh
Kanayo Ikeh
JBJason Botten
Jason Botten
Defective interfering particles (DIPs) profoundly influence viral replication and host responses yet it remains difficult to quantify their activity routinely in the laboratory. Here, using lymphocytic choriomeningitis virus (LCMV) as a model mammarenavirus, we establish complementary approaches for measuring interfering activity of DIPs across a range of experimental scales. First, we optimized plaque-and focus-based interference assays that directly quantify DIP-mediated suppression of standard infectious virus replication through a modified neutralization assay. Second, in cell monolayers saturated with both DIPs and infectious particles, we identified a complete loss of expression of the viral glycoprotein and matrix protein, which are each encoded in the positive-sense orientation of the mammarenavirus genome. Notably, this loss of protein expression mirrors the inhibition of plaque formation traditionally seen in this high DIP setting. The observed DIP-mediated loss of glycoprotein expression is a surrogate marker of interference and was used to develop an alternative assay of DIP activity. This glycoprotein expression assay recapitulated interference detected in traditional high-titer plaque assays (i.e. loss of plaques when all cells are saturated with DIPs and infectious particles) while substantially increasing scalability. These approaches enable sensitive and scalable quantification of DIP activity for LCMV as well as Junín virus and expand our experimental toolkit for studying arenavirus population dynamics, pathogenesis and immunity, and may help advance DIP-based antiviral strategies. This study also provides mechanistic details on how mammarenavirus DIPs interfere with infectious virus propagation.